C-reactiveprotein in community-acquiredsepsis : youcanteach new tricks to an old dog
View/ Open
Date
2011Type
Abstract
Severe sepsis is a major challenge for clinicians caring for acutely ill patients. For many years, several biomarkers have been tested and proposed to improve the ability not only to diagnose but also to anticipate clinical response to antibiotics. Despite the availability of many sophisticated and novel biomarkers, current evidence demonstrates that C-reactive protein (CRP), a well-known and relatively inexpensive biomarker, is useful in the clinical setting. The sequential evaluation of plasm ...
Severe sepsis is a major challenge for clinicians caring for acutely ill patients. For many years, several biomarkers have been tested and proposed to improve the ability not only to diagnose but also to anticipate clinical response to antibiotics. Despite the availability of many sophisticated and novel biomarkers, current evidence demonstrates that C-reactive protein (CRP), a well-known and relatively inexpensive biomarker, is useful in the clinical setting. The sequential evaluation of plasma CRP concentrations in patients with severe sepsis and the interpretation of its patterns may allow assessments of individual prognosis and response to treatment. ...
In
Critical care. Fullerton : Society of Critical Care Medicine. Vol. 15, no. 5 (2011), p. 186 (2 p.)
Source
Foreign
Collections
-
Journal Articles (39401)Health Sciences (10592)
This item is licensed under a Creative Commons License
![](/themes/Mirage2Novo//images/lume/cc.png)